forodesine hydrochloride (BCX-1777)
BCX1777-Bi-04-106
Phase 2 small_molecule completed
Quick answer
forodesine hydrochloride (BCX-1777) for B-cell Acute Lymphoblastic Leukemia is a Phase 2 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- B-cell Acute Lymphoblastic Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed